• español
    • English
    • português
  • português 
    • español
    • English
    • português
  • Página inicial
  • Sitio da OPS
  • Índices
  • Coleção completa
  • Sobre o IRIS
  • Memória Institucional
  • Contato
JavaScript is disabled for your browser. Some features of this site may not work without it.
Ver item 
  •   Página inicial
  • 1.PAHO Headquarters / Sede de la OPS
  • Scientific Journals and Newsletters / Revistas Científicas y Boletines
  • Pan American Journal of Public Health
  • Ver item
  •   Página inicial
  • 1.PAHO Headquarters / Sede de la OPS
  • Scientific Journals and Newsletters / Revistas Científicas y Boletines
  • Pan American Journal of Public Health
  • Ver item

Normas para la publicación de investigaciones clínicas patrocinadas por la industria farmacéutica

Thumbnail
Visualizar/Abrir
16644.pdf (52.10Kb)
Data
2003
Autor
Anon
Metadata
Mostrar registro completo
Resumo
The role played by the private sector, in particular the pharmaceutical industry, in funding research has been growing at an accelerated pace in recent decades. So much so, in fact, that the private sector has become the primary funding source of clinical trials in some countries. As a result, pharmaceutical companies exercise ever-growing control over not only the design of clinical trials but also the publication of their results. The conflicts of interest involved in this kind of situation can lead to ethical breaches (for example, suppression or distortion of results or the intimidation of investigators), and it is crucial to take concrete steps to guard against such breaches. This is exactly what a Working Group made up of members of the pharmaceutical industry itself has done, preparing a series of guidelines for that industry in order to promote good publication practices. These guidelines, which were just recently published in English, represent an important step in efforts to achieve greater transparency and accountability in the presentation of results of research funded by manufacturers of pharmaceutical products. Although the guidelines, now translated into Spanish in this piece, are subject to future revisions, they are a valuable starting point for further discussion of a problem that deserves the urgent attention of the scientific community (AU)
Título traduzido
Publication standards for clinical research sponsored by the pharmaceutical industry
Series
Rev Panam Salud Publica;14(1),jul. 2003
URI
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003000600018&lng=pt&nrm=iso&tlng=es
https://iris.paho.org/handle/10665.2/8472
Cita
Anon (2003) Normas para la publicación de investigaciones clínicas patrocinadas por la industria farmacéutica. Rev Panam Salud Publica;14(1) 62-66,jul. 2003. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892003000600018&lng=pt&nrm=iso&tlng=es
Collections
  • Pan American Journal of Public Health

Navegar

Todo o repositórioComunidades e ColeçõesPor data do documentoAutoresTítulosAssuntosTítulo da SerieTipo de materialIdiomasCategoríaUnidade Técnica/Repesentação de paísEsta coleçãoPor data do documentoAutoresTítulosAssuntosTítulo da SerieTipo de materialIdiomasCategoríaUnidade Técnica/Repesentação de país

Estatística

Ver as estatísticas de uso

Organização Pan-Americana da Saúde
Organização Mundial da Saúde. Escritório Regional para as Américas.
525 Twenty-third Street, N.W., Washington, D.C. 20037, Estados Unidos
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663
email: libraryhq@paho.org

Links

  • Publicações destacadas da OPAS
  • Biblioteca Digital da OMS (IRIS)
  • Biblioteca Virtual em Saúde (BVS)
  • Global Index Medicus (GIM)